Fig. 10

Associations between tumor-infiltrating immune cells (TIICs) and GRGs based riskscore signature in ccRCC; a Dendritic cells resting between high- and low-risk ccRCC patients; b Macrophages M0 between high- and low-risk ccRCC patients; c Macrophages M1 between high- and low-risk ccRCC patients; d Mast cells resting between high- and low-risk ccRCC patients; e Monocytes between high- and low-risk ccRCC patients; f Plasma cells between high- and low-risk ccRCC patients; g T cells CD4 memory activated between high- and low-risk ccRCC patients; h T cells gamma delta between high- and low-risk ccRCC patients; i T cells regulatory (Tregs) between high- and low-risk ccRCC patients; j Radar chart showed the difference of immune cell infiltration abundances in ccRCC subtypes